Rapid evidence‐based sequencing of foundational drugs for heart failure and a reduced ejection fraction
Author:
Affiliation:
1. Baylor University Medical Center Dallas TX USA
2. Imperial College London UK
3. British Heart Foundation Cardiovascular Research Centre University of Glasgow Glasgow UK
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2149
Reference100 articles.
1. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
2. Medical Therapy for Heart Failure With Reduced Ejection Fraction
3. How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?
4. Effects of Enalapril on Mortality in Severe Congestive Heart Failure
5. Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
Cited by 108 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Implementation of guideline-directed medical therapy for heart failure patients with reduced ejection fraction in Belgium: a Delphi panel approach;Acta Cardiologica;2024-09-10
2. Characterization of a new model of chemotherapy-induced heart failure with reduced ejection fraction and nephrotic syndrome in Ren-2 transgenic rats;Hypertension Research;2024-09-09
3. Digital consults in heart failure care: a randomized controlled trial;Nature Medicine;2024-08-31
4. Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum;European Heart Journal - Digital Health;2024-08-30
5. Excess long-term risk of adverse outcomes in heart failure patients with high and low levels of NT-proBNP: A 7-year follow-up study (NorthStar Trial);IJC Heart & Vasculature;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3